Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Pulmonary Aspiration During Anaesthetic Induction
Interventions
DIAGNOSTIC_TEST

Gastric ultrasound

"The sequence in which the study is conducted will be as follows, the first examination (baseline examination) will take place immediately before the appointment and prescription of GLP-1 Analoga (before the first injection). During the examination the gastric content (quality/quantity) will be determined, secondly, a baseline for gastric emptying time after oral intake of 500ml of water is collected (patient drinks water, the stomach emptying will simultaneously be tracked with gastric ultrasound).~In accordance with the first endocrinological control examination (6-8 weeks after therapy initiation) the same gastric ultrasound examination is performed."

All Listed Sponsors
lead

Sascha Battig

OTHER

NCT06659159 - Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying | Biotech Hunter | Biotech Hunter